Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
Clinical trial NCT02334462 · COMPLETED
Trial details
- NCT number
- NCT02334462
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-07
- Primary completion
- 2016-03-31
- Enrollment
- 538
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.